<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001695'>Cardiac arrest</z:hpo> is the leading cause of <z:hpo ids='HP_0011420'>death</z:hpo> in the United States and other developed countries </plain></SENT>
<SENT sid="1" pm="."><plain>Ventricular tachyarrhythmias are the most prominent cause of <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo>, and patients with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> are at increased risk for these <z:mp ids='MP_0004085'>abnormal heart rhythms</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Drug and device therapies have important limitations that make them inadequate to meet this challenge </plain></SENT>
<SENT sid="3" pm="."><plain>We and others have proposed development of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> gene therapy as an alternative to current treatment methods </plain></SENT>
<SENT sid="4" pm="."><plain>In this review, I discuss the basic mechanisms of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and summarize the literature on the use of gene therapy for ventricular tachyarrhythmias </plain></SENT>
</text></document>